CD8+ T cells then interpret external biomolecular cues from their environment, including cytokines and metabolites, to fully establish as CTLs capable of direct tumor cell killing upon cognate peptide: MHC I recognition [45,49–51]. Here, CD8A is linked to neoplasm.